{"title":"研究人员呼吁消除使用丁丙诺啡的药房障碍","authors":"Gary Enos","doi":"10.1002/adaw.34350","DOIUrl":null,"url":null,"abstract":"<p>Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"36 47","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Researchers call for fix to pharmacy-level barriers to buprenorphine\",\"authors\":\"Gary Enos\",\"doi\":\"10.1002/adaw.34350\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"36 47\",\"pages\":\"1-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34350\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34350","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Researchers call for fix to pharmacy-level barriers to buprenorphine
Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
